Back to results
US 2003/0158428 A1Published application
Intermediates and processes for preparing substituted chromanol derivatives
AssigneePfizer Inc.
InventorsKeith M. Devries, Stephane Caron, Philip D. Hammen, Geraldine P. Taber, John L. Tucker, Peter R. Rose, Ronald J. Post, Brian K. Raymer
Life of this patent
Estimating the term…
Abstract
The invention relates to processes for preparing a compound of the formula 1 and the enantiomer of said compound, wherein the benzoic acid moiety is attached at position 6 or 7 of the chroman ring, and R1, R2, and R3 are as defined herein. The invention further relates to intermediates that are useful in the preparation of the compound of formula X above.
Claims12
A process of preparing a compound of formula X having the structure:
- 22
- or the enantiomer of said compound, wherein R1 is —(CH2)qCHR5R6 and q is 0 to 4;
- each R2 and R3 is independently selected from the group consisting of H, fluoro, chloro, C1-C6 alkyl, C1-C6 alkoxy, phenylsulfinyl, phenylsulfonyl, and —S(O)n(C1-C6 alkyl) where n is 0 to 2, and said alkyl group, the alkyl moiety of said alkoxy and —S(O)n(C1-C6 alkyl) groups, and the phenyl moiety of said phenylsulfinyl and phenylsulfonyl groups are substituted by 0 to 3 fluoro groups;
- R5 is H, C1-C6 alkyl, or phenyl substituted by R2;
- R6 is H, C1-C6 alkyl, C3-C8 cycloalkyl, C6-C10 aryl, or 5-10 membered heteroaryl, wherein said aryl and heteroaryl groups are substituted by 1 or 2 substituents independently selected from phenyl, the groups set forth in the definition of R2, and phenyl substituted by 1 or 2 groups set forth in the definition of R2;
- which comprises treating a compound of the formula IX
- 23
- or the enantiomer of said compound of formula IX in the preparation of the enantiomer of said compound of formula X, wherein R1, R2, and R3 are as defined above, with a base.
5 more elements
A process of preparing a compound having formula IX,
- 27
- or the enantiomer of said compound, wherein R1 is —(CH2)qCHR5R6 and q is 0 to 4;
- each R2 and R3 is independently selected from the group consisting of H, fluoro, chloro, C1-C6 alkyl, C1-C6 alkoxy, phenylsulfinyl, phenylsulfonyl, and —S(O)n(C1-C6 alkyl) where n is 0 to 2, and said alkyl group, the alkyl moiety of said alkoxy and —S(O)n(C1-C6 alkyl) groups, and the phenyl moiety of said phenylsulfinyl and phenylsulfonyl groups are substituted by 0 to 3 fluoro groups;
- R5 is H, C1-C6 alkyl, or phenyl substituted by groups set forth in the definition of R2;
- R6 is H, C1-C6 alkyl, C3-C8 cycloalkyl, C6-C10 aryl, or 5-10 membered heteroaryl, wherein said aryl and heteroaryl groups are substituted by 1 or 2 substituents independently selected from phenyl, groups set forth in the definition of R2, and phenyl substituted by 1 or 2 groups set forth in the definition of R2;
- which comprises treating a compound of the formula
- 28
- or the enantiomer of said compound of formula VII in the preparation of the enantiomer of the compound of formula IX, wherein R1 and R2 are as defined above and X is halo or C1-C4 perfluoroalkylsulfonate, with a compound of the formula VIII:
- 29
- wherein R3 is as defined above, in the presence of a base or fluoride salt and a palladium catalyst.
7 more elements
Dependencies are inferred from the claim text.